Mayoly Spindler expands its management team to support the implementation of an ambitious development cycle
As the French and international world of healthcare faces major changes, Mayoly Spindler, committed to a trajectory of growth, is expanding its management team and consolidating its organization to ensure the soundness and vitality of the components of its success.
“In the five years to come, more than half of our growth will come from new products or new countries and our ability to prepare and carry out these launches is crucial. For our pharmaceutical business, France represents—and will continue to represent—around half of our sales revenue. Under increasing strains and facing ongoing redefinition, it is essential that we have a strong framework in France, capable of sustaining its commercial competitiveness, building the future by fostering the development of new professions and know-how, and contributing to Mayoly Spindler’s strategic thinking”, reports Stéphane THIROLOIX, CEO of MAYOLY SPINDLER.